240 related articles for article (PubMed ID: 24563500)
1. The effect of testosterone on cardiovascular disease: a critical review of the literature.
Su JJ; Park SK; Hsieh TM
Am J Mens Health; 2014 Nov; 8(6):470-91. PubMed ID: 24563500
[TBL] [Abstract][Full Text] [Related]
2. Treating men's health holistically: protecting endothelial function early.
Cardiovasc J Afr; 2008; 19(4):230. PubMed ID: 18776975
[No Abstract] [Full Text] [Related]
3. Androgen deficiency in aging and metabolically challenged men.
Shelton JB; Rajfer J
Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
[TBL] [Abstract][Full Text] [Related]
4. Testosterone deficiency.
Traish AM; Miner MM; Morgentaler A; Zitzmann M
Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
Afiadata A; Ellsworth P
Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
[TBL] [Abstract][Full Text] [Related]
6. Hypogonadism management and cardiovascular health.
Auerbach JM; Khera M
Postgrad Med; 2020 Dec; 132(sup4):35-41. PubMed ID: 32799602
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
Chrysant SG; Chrysant GS
Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
[TBL] [Abstract][Full Text] [Related]
8. The dark side of testosterone deficiency: III. Cardiovascular disease.
Traish AM; Saad F; Feeley RJ; Guay A
J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
[TBL] [Abstract][Full Text] [Related]
9. Testosterone deficiency: which patients should you screen and treat?
Sadovsky R; Dhindsa S; Margo K
J Fam Pract; 2007 May; 56(5 Suppl Testosterone):S1-20; quiz S21-3. PubMed ID: 17475159
[No Abstract] [Full Text] [Related]
10. Beneficial and adverse effects of testosterone on the cardiovascular system in men.
Ruige JB; Ouwens DM; Kaufman JM
J Clin Endocrinol Metab; 2013 Nov; 98(11):4300-10. PubMed ID: 24064693
[TBL] [Abstract][Full Text] [Related]
11. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype.
Carrero JJ; Stenvinkel P
Nephrol Dial Transplant; 2012 Nov; 27(11):4030-41. PubMed ID: 22962412
[TBL] [Abstract][Full Text] [Related]
12. Testosterone deficiency in older men: a problem worth treating.
McHenry Martin C
Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515
[TBL] [Abstract][Full Text] [Related]
13. [Male hypogonadism and civilization diseases].
Stárka L
Cas Lek Cesk; 2012; 151(2):69-72. PubMed ID: 22515012
[TBL] [Abstract][Full Text] [Related]
14. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner MM; Seftel AD
Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
[TBL] [Abstract][Full Text] [Related]
15. [Testosterone supplementary therapy for type-2 diabetes mellitus males with hypogonadism: Controversy and analysis].
Cheng Z; Zhang LY; Chen GM; He W; Cai K; Liao ZH
Zhonghua Nan Ke Xue; 2017 Aug; 23(8):739-744. PubMed ID: 29726651
[TBL] [Abstract][Full Text] [Related]
16. [Testosterone: a treatment for the prevention of cardiovascular disease].
Gencer B; Köhler Ballan B; Philippe J; Mach F
Rev Med Suisse; 2014 May; 10(432):1173-8. PubMed ID: 24964524
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular issues in hypogonadism and testosterone therapy.
Shabsigh R; Katz M; Yan G; Makhsida N
Am J Cardiol; 2005 Dec; 96(12B):67M-72M. PubMed ID: 16387571
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania.
Haring R; Ittermann T; Völzke H; Krebs A; Zygmunt M; Felix SB; Grabe HJ; Nauck M; Wallaschofski H
Aging Male; 2010 Dec; 13(4):247-57. PubMed ID: 20504090
[TBL] [Abstract][Full Text] [Related]
19. Testosterone therapy in men.
Theodoraki A; Bouloux PM
Menopause Int; 2009 Jun; 15(2):87-92. PubMed ID: 19465676
[TBL] [Abstract][Full Text] [Related]
20. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.
Shigehara K; Sugimoto K; Konaka H; Iijima M; Fukushima M; Maeda Y; Mizokami A; Koh E; Origasa H; Iwamoto T; Namiki M
Aging Male; 2011 Mar; 14(1):53-8. PubMed ID: 21171937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
